Page 238 - HIVMED_v21_i1.indb

Page 11 of 11 Review Article

12. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items 22. Teasdale CA, Wang C, Francois U, et al. Time to initiation of antiretroviral therapy
for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med. amongst patients who Are ART eligible in Rwanda: Improvement over time.
2009;151(4):264–269. https://doi.org/10.7326/0003-4819-151-4-200908180-00135 J Acquir Immun Defic Syndr. 2015;68(3):314–321. https://doi.org/10.1097/QAI.
13. Ambia J, Renju J, Wringe A, et al. From policy to practice: Exploring the 0000000000000432
implementation of antiretroviral therapy access and retention policies between 23. Konings E, Ambaw Y, Dilley K, Gichangi P, Arega T, Crandall B. Implications of
2013 and 2016 in six sub-Saharan African countries. BMC Health Serv Res. adopting new WHO guidelines for antiretroviral therapy initiation in Ethiopia.
2017;17(1):758. https://doi.org/10.1186/s12913-017-2678-1 Bull World Health Organ. 2012;90(9):659–663. https://doi.org/10.2471/BLT.11.
14. Burrage A, Patel M, Mirkovic K, et al. Trends in antiretroviral therapy eligibility and 089599
coverage amongst children aged < 15 years with HIV infection – 20 PEPFAR- 24. Walsh F, Bärnighausen T, Delva W, et al. Impact of early initiation versus national
supported sub-Saharan African countries, 2012–2016. MMWR Morb Mortal Wkly standard of care of antiretroviral therapy in Swaziland’s public sector health system:
Rep. 2018;67(19):552–555. https://doi.org/10.15585/mmwr.mm6719a4 Study protocol for a stepped-wedge randomized trial. Trials. 2017;18(1):383.
15. Plazy M, Dabis F, Naidu K, Orne-Gliemann J, Barnighausen T, Dray-Spira R. Change https://doi.org/10.1186/s13063-017-2128-8
of treatment guidelines and evolution of ART initiation in rural South Africa: Data 25. Mutimura E, Addison D, Anastos K, et al. Trends in and correlates of CD4+ cell
of a large HIV care and treatment programme. BMC Infect Dis. 2015;15:452. count at antiretroviral therapy initiation after changes in national ART guidelines
https://doi.org/10.1186/s12879-015-1207-2 in Rwanda. AIDS (London, England). 2015;29(1):67–76. https://doi.org/10.1097/
16. Song A, Liu X, Huang X, et al. From CD4-based initiation to treating all HIV-infected QAD.0000000000000520
adults immediately. Front Immunol. 2018;9:212. https://doi.org/10.3389/fimmu. 26. Mikkelsen E, Hontelez JAC, Nonvignon J, et al. The costs of HIV treatment and care
2018.00212 in Ghana. AIDS (London, England). 2017;31(16):2279–2286. https://doi.org/
17. Duber HC, Dansereau E, Masters SH, et al. Uptake of WHO recommendations for 10.1097/QAD.0000000000001612
first-line antiretroviral therapy in Kenya, Uganda, and Zambia. PLoS One. 27. Venter WDF, Moorhouse M, Sokhela S, et al. Dolutegravir plus two different
2015;10(3):e0120350. https://doi.org/10.1371/journal.pone.0120350 prodrugs of tenofovir to treat HIV. N Engl J Med. 2019;381(9):803–815. https://
18. Hontelez JA, De Vlas SJ, Tanser F, et al. The impact of the new WHO antiretroviral doi.org/10.1056/NEJMoa1902824
treatment guidelines on HIV epidemic dynamics and cost in South Africa. PLoS 28. Mehraj V, Cox J, Lebouché B, et al. Socio-economic status and time trends
One. 2011;6(7):e21919. https://doi.org/10.1371/journal.pone.0021919 associated with early ART initiation following primary HIV infection in Montreal,
19. Ross E, Tanser F, Pei P, et al. The impact of the 2013 WHO antiretroviral therapy Canada: 1996 to 2015. J Int AIDS Soc. 2018;21(2):1-N.PAG. https://doi.
guidelines on the feasibility of HIV population prevention trials. HIV Clin Trials. org/10.1002/jia2.25034
2014;15(5):185–198. https://doi.org/10.1310/hct1505-185
29. Suarez-Garcia I, Gonzalez J, Berenguer J, et al. Reasons for noncompliance with
20. Stanecki K, Daher J, Stover J, Beusenberg M, Souteyrand Y, Garcia Calleja JM. the national guidelines for initial antiretroviral therapy of HIV-infected patients in
Antiretroviral therapy needs: The effect of changing global guidelines. Sex Transm Spain, 2010–2015. Enfermed Infecc Microbiol Clin. 2019;37(9):580–587. https://
Infect. 2010;86(Suppl 2):ii62–ii66. https://doi.org/10.1136/sti.2010.046177 doi.org/10.1016/j.eimc.2019.02.007
21. Labhardt ND, Sello M, Lejone T, et al. Adoption of new HIV treatment guidelines 30. Larsen A, Cheyip M, Tesfay A, et al. Timing and predictors of initiation on
and drug substitutions within first-line as a measure of quality of care in rural antiretroviral therapy amongst newly-diagnosed HIV-infected persons in
Lesotho: Health centers and hospitals compared. Trop Med Int Health. South Africa. AIDS Behav. 2019;23(2):375–385. https://doi.org/10.1007/s10461-
2012;17(10):1245–1254. https://doi.org/10.1111/j.1365-3156.2012.03051.x 018-2222-2

http://www.sajhivmed.org.za 230 Open Access